Commercial Services and Supplies
Company Overview of Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America (PhRMA) represents the research-based pharmaceutical and biotechnology companies. The company advocates for public policies that encourage discovery of new medicines for patients by pharmaceutical and biotechnology research companies. Its members consist of 3M Pharmaceuticals, Berlex Laboratories, Inc., GE Healthcare, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Wyeth, and Pfizer Inc. PhRMA was founded in 1958 and is based in Washington, DC.
950 F Street, NW
Washington, DC 20004
Founded in 1958
Key Executives for Pharmaceutical Research and Manufacturers of America
Chief Executive Officer and President
President of International Section
Senior Vice President of External Affairs
Senior Vice President of Communications
Compensation as of Fiscal Year 2015.
Pharmaceutical Research and Manufacturers of America Key Developments
Pharmaceutical Research and Manufacturers of America Announces Executive Changes
May 15 15
Pharmaceutical Research and Manufacturers of America President and Chief Executive Officer John J. Castellani announced that Executive Vice President, Administration, and Chief Financial Officer Del Persinger will retire effective May 31, concluding 18-1/2 years leading the organization's finance and operations functions. Paul A. Aines, currently Chief Financial Officer and Senior Director of the American Society of Clinical Oncology (ASCO), will succeed Persinger. Aines will start at PhRMA on June 15. Persinger joined PhRMA in 1996 after 21 years at the American Petroleum Institute. He started his career as a refinery process engineer at Exxon Company.
Pharmaceutical Research and Manufacturers of America Names Timothy P. Walbert to Board of Directors
Apr 28 15
Horizon Pharma plc announced that Timothy P. Walbert, chairman, president and chief executive officer, was elected to the board of directors of the Pharmaceutical Research and Manufacturers of America.
Pharmaceutical Research and Manufacturers of America Announces Executive and Board Changes
Apr 17 15
Kenneth C. Frazier, chairman and chief executive officer (CEO) of Merck & Co. Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). At Board meeting, PhRMA's president and CEO John J. Castellani announced that he will be retiring effective January 1, 2016. Frazier formerly held the position of chairman-elect and succeeds Ian C. Read, chairman and CEO of Pfizer Inc. Also elected were George A. Scangos, Ph.D., CEO of Biogen, as chairman-elect of the PhRMA Board of Directors and Joaquin Duato, worldwide chairman, pharmaceuticals, Johnson & Johnson, as Board treasurer. Before becoming chairman and CEO of Merck in 2011, Frazier served as president of Merck. Dr. Scangos was appointed CEO of Biogen in June 2010. Castellani will step down as president and CEO of PhRMA after successfully leading the association since September 2010. Frazier announced that the search for Castellani's successor will begin immediately and will be led by the PhRMA Board's Nominations and Compensation Committee. Korn Ferry has been retained to conduct the search.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|